21-04-2026 19:52 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On:MUTUAL FUNDS
Mutual Fund
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activity
All Holding
Whats In / Out
MF Trends
MF Tools
Category Returns
AMC:  Category : Scheme :
Detailed Portfolio
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment InPercentage of NAVNo. of sharesValue(Rs in cr)
Domestic EquitiesSun Pharmaceutical Industries Limited11.804414194524.9426
Domestic EquitiesDivi's Laboratories Limited8.77313117118.5374
Domestic EquitiesApollo Hospitals Enterprise Limited6.59531878413.9358
Domestic EquitiesMax Healthcare Institute Limited5.497912072111.6170
Domestic EquitiesTorrent Pharmaceuticals Limited5.28192644611.1607
Domestic EquitiesAurobindo Pharma Limited4.99158085810.5471
Domestic EquitiesLupin Limited4.1993383478.8731
Domestic EquitiesLaurus Labs Limited3.6492776757.7108
Domestic EquitiesAlkem Laboratories Limited3.1230124536.5988
Domestic EquitiesFortis Healthcare Limited2.9148774716.1589
Domestic EquitiesNeuland Laboratories Limited2.658146705.6166
Domestic EquitiesAster DM Healthcare Limited2.3229732574.9082
Domestic EquitiesAbbott India Limited2.318018904.8979
Domestic EquitiesGlenmark Pharmaceuticals Limited2.1485212964.5397
Domestic EquitiesCohance Lifesciences Limited2.08681462714.4093
Domestic EquitiesDr. Reddy's Laboratories Limited1.8728315343.9572
Domestic EquitiesMankind Pharma Limited1.8538195293.9171
Domestic EquitiesSai Life Sciences Limited1.8214395953.8486
Domestic EquitiesIPCA Laboratories Limited1.7041224883.6008
Domestic EquitiesCipla Limited1.6681287923.5247
Domestic EquitiesPark Medi World Limited1.49401660943.1568
Domestic EquitiesLinde India Limited1.391242952.9395
Domestic EquitiesBiocon Limited1.2930757062.7322
Domestic EquitiesSBI Life Insurance Company Limited1.2474148302.6357
Domestic EquitiesHealthcare Global Enterprises Limited1.2444500662.6295
Domestic EquitiesSumitomo Chemical India Limited1.2101701582.5569
Domestic EquitiesFDC Limited1.1576761792.4461
Domestic EquitiesOnesource Specialty Pharma Limited1.1476164592.4249
Domestic EquitiesRainbow Childrens Medicare Limited1.1091201502.3436
Domestic EquitiesShaily Engineering Plastics Limited1.1078112302.3408
Domestic EquitiesPiramal Pharma Limited1.09951701522.3233
Domestic EquitiesJubilant Ingrevia Limited1.0571410812.2336
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited0.995492132.1033
Domestic EquitiesOrchid Pharma Limited0.8279362581.7493
Domestic EquitiesShilpa Medicare Limited0.8185495681.7294
Domestic EquitiesStandard Engineering Technology Ltd0.81681633571.7259
Domestic EquitiesCaplin Point Laboratories Limited0.7442104491.5724
Domestic EquitiesZydus Lifesciences Limited0.6923167921.4629
Domestic EquitiesAstraZeneca Pharma India Limited0.690918801.4599
Domestic EquitiesPoly Medicure Limited0.6789120441.4346
Domestic EquitiesSupriya Lifescience Limited0.6746253701.4255
Domestic EquitiesSyngene International Limited0.4118223150.8701
Total 99.1952 209.5985
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)0.8048 1.7006
Total 0.8048 1.7006
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.